Find My Journal

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu, Yi Hu, Guangwei Luo, Ke Wang, Yang Lü, Huadong Li, Shuzhen Wang, Shunan Ruan, Haijun Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, Xianzhi Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, Fei Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, Lianhan Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Yan Wan, Hong Qin, Yushen Jiang, Thomas Jaki, Frederick G. Hayden, Peter Horby, Bin Cao, Chen Wang

The Lancet, 2020

China-Japan Friendship Hospital, Capital Medical University, Huazhong University of Science and Technology, Tongji Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Wuhan Pulmonary Hospital, Wuhan Union Hospital, Wuhan Third Hospital, Wuhan University, Renmin Hospital of Wuhan University, Zhongnan Hospital of Wuhan University, Wuhan Puai Hospital, Central Hospital of Wuhan, Tsinghua University, Beijing University of Chinese Medicine, Zhejiang Lab, Shanghai Clinical Research Center, University of Cambridge, Lancaster University, University of Virginia, University of Oxford, Peking University, Center for Life Sciences, Peking Union Medical College Hospital

View Free PDF Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

3653

Citations

View on Google Scholar